Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Vomiting 1 Endometrial Neoplasms 1 Cachexia 1 Anorexia 1

Interventions

Paclitaxel 95 Carboplatin 77 pembrolizumab 74 Cisplatin 29 Bevacizumab 27 Letrozole 22 Radiotherapy 21 Doxorubicin 21 Megestrol Acetate 20 lenvatinib 19 olaparib 18 Taxes 17 Docetaxel 17 Nivolumab 16 Specimen Handling 15 Metformin 15 dostarlimab 14 Magnetic Resonance Spectroscopy 14 Gemcitabine 13 durvalumab 12 Medroxyprogesterone Acetate 12 Trastuzumab 11 Indocyanine Green 11 Fulvestrant 11 Biopsy 11 temsirolimus 10 abemaciclib 10 atezolizumab 9 Radiation 9 Early Intervention, Educational 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Endometrial Neoplasms × Megestrol × Clear all

NCT05332483 2023-11-03

MA-EEC

Sunnybrook Health Sciences Centre

Phase 1 Terminated

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡